209 related articles for article (PubMed ID: 7687635)
21. CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis.
Brooimans RA; Van der Ark AA; Tomita M; Van Es LA; Daha MR
Eur J Immunol; 1992 Mar; 22(3):791-7. PubMed ID: 1372260
[TBL] [Abstract][Full Text] [Related]
22. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
Niehans GA; Cherwitz DL; Staley NA; Knapp DJ; Dalmasso AP
Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
[TBL] [Abstract][Full Text] [Related]
23. The possible role of membrane complement regulators in vasculitis.
Daha MR
Behring Inst Mitt; 1993 Aug; (92):184-90. PubMed ID: 7504449
[TBL] [Abstract][Full Text] [Related]
24. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
Hakulinen J; Meri S
Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
[TBL] [Abstract][Full Text] [Related]
25. Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.
Shimo K; Mizuno M; Nasu J; Hiraoka S; Makidono C; Okazaki H; Yamamoto K; Okada H; Fujita T; Shiratori Y
J Gastroenterol Hepatol; 2004 Jun; 19(6):643-7. PubMed ID: 15151618
[TBL] [Abstract][Full Text] [Related]
26. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
Simpson KL; Jones A; Norman S; Holmes CH
Am J Pathol; 1997 Nov; 151(5):1455-67. PubMed ID: 9358772
[TBL] [Abstract][Full Text] [Related]
27. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells.
Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T
Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580
[TBL] [Abstract][Full Text] [Related]
28. Cell-surface expression of complement restriction factors and sialyl Lewis antigens in oral carcinoma: relevance to chemo-immunotherapy.
Ravindranath NM; Nishimoto K; Chu K; Shuler C
Anticancer Res; 2000; 20(1A):21-6. PubMed ID: 10769630
[TBL] [Abstract][Full Text] [Related]
29. [Kidney and complement regulatory factors].
Matsuo S
Nihon Rinsho Meneki Gakkai Kaishi; 1995 Dec; 18(6):643-6. PubMed ID: 8963771
[No Abstract] [Full Text] [Related]
30. ''Homologous restriction'' in complement lysis: roles of membrane complement regulators.
Morgan BP; Berg CW; Harris CL
Xenotransplantation; 2005 Jul; 12(4):258-65. PubMed ID: 15943774
[TBL] [Abstract][Full Text] [Related]
31. Cell-surface density of complement restriction factors (CD46, CD55, and CD59): oral squamous cell carcinoma versus other solid tumors.
Ravindranath NM; Shuler C
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Feb; 103(2):231-9. PubMed ID: 17234541
[TBL] [Abstract][Full Text] [Related]
32. Expression of complement regulatory proteins on human natural killer cell subsets.
Wang L; Halliday D; Johnson PM; Christmas SE
Immunol Lett; 2007 Oct; 112(2):104-9. PubMed ID: 17719652
[TBL] [Abstract][Full Text] [Related]
33. Human complement regulator expression by the normal female reproductive tract.
Oglesby TJ; Longwith JE; Huettner PC
Anat Rec; 1996 Sep; 246(1):78-86. PubMed ID: 8876826
[TBL] [Abstract][Full Text] [Related]
34. Complement activated by chimeric anti-folate receptor antibodies is an efficient effector system to control ovarian carcinoma.
Macor P; Mezzanzanica D; Cossetti C; Alberti P; Figini M; Canevari S; Tedesco F
Cancer Res; 2006 Apr; 66(7):3876-83. PubMed ID: 16585216
[TBL] [Abstract][Full Text] [Related]
35. Immunobiology of the human placental trophoblast.
Johnson PM
Exp Clin Immunogenet; 1993; 10(2):118-22. PubMed ID: 8251180
[TBL] [Abstract][Full Text] [Related]
36. CD59 efficiently protects human NT2-N neurons against complement-mediated damage.
Pedersen ED; Aass HC; Rootwelt T; Fung M; Lambris JD; Mollnes TE
Scand J Immunol; 2007; 66(2-3):345-51. PubMed ID: 17635812
[TBL] [Abstract][Full Text] [Related]
37. CD55 limits sensitivity to complement-dependent cytolysis triggered by heterologous expression of α-gal xenoantigen in colon tumor cells.
Wu Y; Wang Y; Qin F; Wang Z; Wang Y; Yang Y; Zheng H; Wang Y
Am J Physiol Gastrointest Liver Physiol; 2014 Jun; 306(12):G1056-64. PubMed ID: 24763553
[TBL] [Abstract][Full Text] [Related]
38. CD59: a molecule involved in antigen presentation as well as downregulation of membrane attack complex.
Venneker GT; Asghar SS
Exp Clin Immunogenet; 1992; 9(1):33-47. PubMed ID: 1379443
[TBL] [Abstract][Full Text] [Related]
39. Therapeutic inhibition of the complement system.
Makrides SC
Pharmacol Rev; 1998 Mar; 50(1):59-87. PubMed ID: 9549758
[TBL] [Abstract][Full Text] [Related]
40. C-reactive protein upregulates complement-inhibitory factors in endothelial cells.
Li SH; Szmitko PE; Weisel RD; Wang CH; Fedak PW; Li RK; Mickle DA; Verma S
Circulation; 2004 Feb; 109(7):833-6. PubMed ID: 14967730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
